Club drugs and HIV infection: a review

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Grant Colfax, Robert Guzman

Abstract

Club drug use is common among populations with human immunodeficiency virus (HIV) and populations at high risk for HIV infection. Club drugs have a myriad of acute and chronic medical consequences. Club drug-related visits to the emergency department and admissions for treatment of substance use have increased dramatically over the past 15 years. Most epidemiological data support the role of club drugs in increasing sexual risk behavior, with some studies demonstrating an independent association between use of certain club drugs and HIV infection. The direct influence of club drugs on progression of HIV disease remains to be determined; however, club drugs may interact with certain retroviral medications and have been associated with decreased adherence to medication. Clinicians should ask all patients about patterns of club drug use, counsel patients about the risks associated with club drug use, and refer patients to appropriate behavioral treatment programs for substance use when clinically indicated.

References

Jan 1, 1989·Neuroscience and Biobehavioral Reviews·M Mamelak
Aug 1, 1994·AIDS·S P BuchbinderS D Holmberg
Dec 16, 1998·Lancet·J A Henry, I R Hill
May 4, 1999·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·E StoneS P Buchbinder
Jun 30, 2000·The American Journal of Psychiatry·R L KlitzmanJ I Hudson
Nov 1, 2000·JAMA : the Journal of the American Medical Association·M BaggottJ Zehnder
Nov 9, 2000·The New England Journal of Medicine·J PaukL Corey
Dec 6, 2000·Journal of Psychopharmacology·T R PhillipsS J Henriksen
Jan 11, 2000·Emergency Medicine Clinics of North America·K A Graeme
May 8, 2001·Human & Experimental Toxicology·P Dupont, J Thornton
Jun 8, 2001·American Journal of Public Health·G ManserghS Buchbinder
Jul 31, 2001·Journal of Psychoactive Drugs·K L Jansen, R Darracot-Cankovic
Sep 8, 2001·Journal of Substance Abuse·A M MattisonUNKNOWN San Diego HIV Neurobehavioral Research Center Group
Oct 3, 2001·The American Journal on Addictions·K MiottoR Rawson
Nov 15, 2001·Journal of Acquired Immune Deficiency Syndromes : JAIDS·G N ColfaxS Buchbinder
Jan 5, 2002·Pharmacotherapy·C J Teter, S K Guthrie
Mar 7, 2002·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Paolo GiunchediMilena Sorrenti
Mar 13, 2002·Pharmacology, Biochemistry, and Behavior·Stephen J Kish
Jun 8, 2002·Journal of Neurovirology·Mikhail A GavrilinMichael Podell
Jun 22, 2002·Anaesthesia and Intensive Care·H R PalR Ray
Sep 11, 2002·Journal of Substance Abuse Treatment·Richard A RawsonPaul Brethen
Sep 11, 2002·Journal of Substance Abuse Treatment·Thomas E FreeseCathy J Reback
Sep 24, 2002·The Annals of Pharmacotherapy·Tony Antoniou, Alice Lin-In Tseng
Nov 20, 2002·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Amy Rock WohlPaul A Simon
Feb 27, 2003·Addiction·Erkki VuoriMatti Jäntti
May 3, 2003·The American Journal of Psychiatry·Junchao TongStephen J Kish
May 16, 2003·Toxicology·Hany Z RofaelMohamed S Abdel-Rahman
Aug 21, 2003·The Journal of Neuropsychiatry and Clinical Neurosciences·Thomas E NordahlMartin Leamon
Nov 6, 2003·American Journal of Public Health·Hanne ThiedeUNKNOWN Young Men's Survey Study Group
Dec 16, 2003·The Journal of Infectious Diseases·Ronald J EllisUNKNOWN HIV Neurobehavioral Research Center Group
Dec 17, 2003·Acta Psychiatrica Scandinavica·S TardieuO Blin

❮ Previous
Next ❯

Citations

Aug 21, 2007·AIDS and Behavior·Matthew EppersonMingway Chang
Mar 16, 2011·AIDS and Behavior·Glenn-Milo SantosGrant Nash Colfax
Dec 26, 2001·Journal of Clinical Epidemiology·A C JusticeUNKNOWN Adult AIDS Clinical Trials Unit Outcomes Committee
Feb 11, 2011·Journal of Psychoactive Drugs·Hugh KleinClaire E Sterk
Jun 6, 2009·Culture, Health & Sexuality·Michael Hurley, Garrett Prestage
Mar 5, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Katerina A ChristopoulosGrant N Colfax
Jul 12, 2013·AIDS·Chris BeyrerKenneth Mayer
Jan 10, 2012·Current Opinion in Pediatrics·Matthew D Zuckerman, Edward W Boyer
Aug 21, 2012·Sexually Transmitted Diseases·Frances ValenciaNigel Bourne
May 17, 2007·International Journal of Clinical Practice·L Waters, M Nelson
Oct 5, 2006·Harm Reduction Journal·Valerie J RoseWilli McFarland
Feb 19, 2014·Nature Reviews. Urology·Sean C Skeldon, S Larry Goldenberg
Jul 23, 2013·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Kenneth H MayerSteven A Safren
May 30, 2013·Social Psychiatry and Psychiatric Epidemiology·Yingying DingRoger Detels
Jan 23, 2016·Drug and Alcohol Dependence·Heng ZhangSten H Vermund
Mar 10, 2007·Brain, Behavior, and Immunity·Kathy L KopniskyYu Woody Lin
Jun 23, 2015·Journal of Psychoactive Drugs·Yingying DingRoger Detels
Dec 23, 2009·Substance Use & Misuse·Xiushi Yang, Guomei Xia
May 23, 2015·Frontiers in Cellular Neuroscience·Dongliang JiaoMin Zhao
Aug 12, 2016·International Journal of Environmental Research and Public Health·Yansheng YanXun Lin
Sep 9, 2016·Substance Use & Misuse·Chen ZhangSten H Vermund
Apr 15, 2008·Emergency Medicine Clinics of North America·Catherine A Marco, Richard E Rothman
Nov 13, 2016·Drug and Alcohol Dependence·Daniel J FeasterLisa R Metsch
Oct 7, 2009·Qualitative Health Research·Jeffrey P AguinaldoLiviana Calzavara
Dec 22, 2017·Sexual Health·Vivienne Smith, Fiona Tasker
May 18, 2018·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Typhanye V DyerSteve Shoptaw

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.